« Back to Record
Galmarini, C. M., Treilleux, I., Cardoso, F., Bernard, C., Durbecq, V., Gancberg, D., Bissery, M. C., Paesmans, M., Larsimont, D., Piccart-Gebhart, M., Di Leo, A., & Dumontet, C. (2008). Class III beta-tubulin isotype predicts response in advanced breast cancer patients randomly treated either with single-agent doxorubicin or docetaxel. Clinical cancer research, 14(14), 4511-4516. doi:10.1158/1078-0432.CCR-07-4741
Citation APA
Permalink
Permalink
http://hdl.handle.net/2013/ULB-DIPOT:oai:dipot.ulb.ac.be:2013/55758



